Previzion Aksyon Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals
Dernie pri$42.66Mizajou 25 Sep 2026 19:59 UTC
Chanjman-1.50%
Previzyon AI: SUPN
AI a pibliye yon pri objektif pou pwochen jou trading la, fen semenn nan ak fen mwa nan. Chanjman an mezire depi dènye pri a. Se estimasyon estatistik, se pa konsèy envestisman.
Pri lor dernie 6 mwa
Premium montre bann objektif pri AI pou 1 zour, 1 semenn ek 1 mwa pou sa aksyon la ek pou tou lot aksyon.
Debloke Premium🔒 Historik previzion
Historik previzion an — chak ansyen previzion bò kote klotir reyèl la — fè pati Premium.
Debloke PremiumSou Konpayi Sa a
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and delivers patented medicines for the treatment of central nervous system disorders and diseases, including clinical-stage candidates for neurological and psychiatric conditions such as epilepsy, conductive disorder, Parkinson’s disease, ADHD and depression.
